Combined effects of pericytes in the tumor microenvironment

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Ribeiro, Aline Lopes ^a   Okamoto, Oswaldo Keith ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANGIOGENIC ACTIVITY; CANCER STEM CELL; DISTANT METASTASIS; HUMAN; IMMUNE EVASION; IMMUNOMODULATION; LUNG METASTASIS; LYMPH NODE METASTASIS; MESENCHYMAL STEM CELL; NEURAL STEM CELL; NONHUMAN; PERICYTE; PRIORITY JOURNAL; REVIEW; THERAPY RESISTANCE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

EID: 84929358929     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/868475     Document Type: Review

References (89)

1. K. Pietras and A. Östman, "Hallmarks of cancer: Interactions with the tumor stroma," Experimental Cell Research, vol. 316, no. 8, pp. 1324-1331, 2010.
2. C. Rouget, "Memoire sur le developpement, la structures et les proprieties des capillaires sanguins et lymphatiques," Archivos de Histología Normal y Patológica, vol. 5, pp. 603-633, 1873.
3. K. W. Zimmermann, "Der feinere bau der blutcapillares," Zeitschrift für Anatomie und Entwicklungsgeschichte, vol. 68, pp. 3-109, 1923.
4. D. E. Sims, "The pericyte-A review," Tissue & Cell, vol. 18, no. 2, pp. 153-174, 1986.
5. L. Díaz-Flores, R. Gutiérrez, J. F. Madrid et al., "Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche," Histology and Histopathology, vol. 24, no. 7, pp. 909-969, 2009.
6. A. Armulik, G. Genové, and C. Betsholtz, "Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises," Developmental Cell, vol. 21, no. 2, pp. 193-215, 2011.
7. R. O. Schlingemann, F. J. R. Rietveld, F. Kwaspen, P. C. M. van de Kerkhof, R. M. W. De Waal, and D. J. Ruiter, "Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue," American Journal of Pathology, vol. 138, no. 6, pp. 1335-1347, 1991.
8. A. Birbrair, T. Zhang, Z.-M. Wang et al., "Role of pericytes in skeletal muscle regeneration and fat accumulation," Stem Cells and Development, vol. 22, no. 16, pp. 2298-2314, 2013.
9. A. Birbrair, T. Zhang, Z.-M. Wang et al., "Skeletal muscle pericyte subtypes differ in their differentiation potential," Stem Cell Research, vol. 10, no. 1, pp. 67-84, 2013.
10. A. Birbrair, T. Zhang, Z.-M. Wang, M. L. Messi, A. Mintz, and O. Delbono, "Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle," The American Journal of Physiology-Cell Physiology, vol. 305, no. 11, pp. C1098-C1113, 2013.
11. G. Bergers and S. Song, "The role of pericytes in blood-vessel formation and maintenance," Neuro-Oncology, vol. 7, no. 4, pp. 452-464, 2005.
12. D. Ribatti, B. Nico, and E. Crivellato, "The role of pericytes in angiogenesis," International Journal of Developmental Biology, vol. 55, no. 3, pp. 261-268, 2011.
13. H. Gerhardt and C. Betsholtz, "Endothelial-pericyte interactions in angiogenesis," Cell and Tissue Research, vol. 314, no. 1, pp. 15-23, 2003.
14. R. Balabanov, R. Washington, J. Wagnerova, and P. Dore-Duffy, "CNS microvascular pericytes express macrophage-like function, cell surface integrin αM, andmacrophage marker ED-2," Microvascular Research, vol. 52, no. 2, pp. 127-142, 1996.
15. M. Crisan, S. Yap, L. Casteilla et al., "A perivascular origin for mesenchymal stem cells in multiple human organs," Cell Stem Cell, vol. 3, no. 3, pp. 301-313, 2008.
16. E. Goldmann, "The growth ofmalignant disease inman and the lower animalswith special reference to the vascular system,"The Lancet, vol. 170, no. 4392, pp. 1236-1240, 1907.
17. J. Folkman, "Tumor angiogenesis: Therapeutic implications," The New England Journal of Medicine, vol. 285, no. 21, pp. 1182-1186, 1971.
18. P. M. Gullino, "Angiogenesis and oncogenesis," Journal of the National Cancer Institute, vol. 61, no. 3, pp. 639-643, 1978.
19. A. Armulik, A. Abramsson, and C. Betsholtz, "Endothelial/ pericyte interactions," Circulation Research, vol. 97,no. 6, pp. 512-523, 2005.
20. W. B. Saunders, B. L. Bohnsack, J. B. Faske et al., "Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3," The Journal of Cell Biology, vol. 175, no. 1, pp. 179-191, 2006.
21. P. C. Stapor, R. S. Sweat, D. C. Dashti, A. M. Betancourt, and W. L. Murfee, "Pericyte dynamics during angiogenesis: New insights from new identities," Journal of Vascular Research, vol. 51, no. 3, pp. 163-174, 2014.
22. P. Lindblom, H. Gerhardt, S. Liebner et al., "Endothelial PDGFB retention is required for proper investment of pericytes in the microvessel wall," Genes and Development, vol. 17, no. 15, pp. 1835-1840, 2003.
23. J. T.Durham, H. K. Surks, B. M. Dulmovits, and I.M.Herman, "Pericyte contractility controls endothelial cell cycle progression and sprouting: Insights into angiogenic switch mechanics," American Journal of Physiology: Cell Physiology, vol. 307, no. 9, pp. C878-C892, 2014.
24. A. Geevarghese and I. M. Herman, "Pericyte-endothelial crosstalk: Implications and opportunities for advanced cellular therapies," Translational Research, vol. 163, no. 4, pp. 296-306, 2014.
25. U. Ozerdem andW. B. Stallcup, "Early contribution of pericytes to angiogenic sprouting and tube formation," Angiogenesis, vol. 6, no. 3, pp. 241-249, 2003.
26. F. J.Huang,W.K.You,P.Bonaldo,T.N. Seyfried, E. B. Pasquale, and W. B. Stallcup, "Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse," Developmental Biology, vol. 344, no. 2, pp. 1035-1046, 2010.
27. E. Ruoslahti, "Specialization of tumour vasculature," Nature Reviews Cancer, vol. 2, no. 2, pp. 83-90, 2002.
28. P. Baluk, S. Morikawa, A. Haskell, M. Mancuso, and D. M. McDonald, "Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors," The American Journal of Pathology, vol. 163, no. 5, pp. 1801-1815, 2003.
29. H. Hashizume, P. Baluk, S.Morikawa et al., "Openings between defective endothelial cells explain tumor vessel leakiness," The American Journal of Pathology, vol. 156, no. 4, pp. 1363-1380, 2000.
30. M. Hellström, H. Gerhardt, M. Kalén et al., "Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis," The Journal of Cell Biology, vol. 152, no. 3, pp. 543-554, 2001.
31. K. D. Barlow, A. M. Sanders, S. Soker, S. Ergun, and L. J. Metheny-Barlow, "Pericytes on the tumor vasculature: Jekyll or hyde?" Cancer Microenvironment, vol. 6, no. 1, pp. 1-17, 2013.
32. A. Raza, M. J. Franklin, and A. Z. Dudek, "Pericytes and vessel maturation during tumor angiogenesis and metastasis," American Journal of Hematology, vol. 85, no. 8, pp. 593-598, 2010.
33. S. Morikawa, P. Baluk, T. Kaidoh, A. Haskell, R. K. Jain, and D. M. McDonald, "Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors," The American Journal of Pathology, vol. 160, no. 3, pp. 985-1000, 2002.
34. Y. Cao, Z.-L. Zhang, M. Zhou et al., "Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma," Cancer, vol. 119, no. 2, pp. 313-334, 2013.
35. Y. Yonenaga, A. Mori, H. Onodera et al., "Absence of smooth muscle actin-positive pericyte coverage of tumor vessels correlates with hematogenous metastasis and prognosis of colorectal cancer patients," Oncology, vol. 69, no. 2, pp. 159-166, 2005.
36. L. Zhang, H. Nishihara, and M. R. Kano, "Pericyte-coverage of human tumor vasculature and nanoparticle permeability," Biological and Pharmaceutical Bulletin, vol. 35, no. 5, pp. 761-766, 2012.
37. M. B. O'Keeffe, A. H. Devlin, A. J. Burns et al., "Investigation of pericytes, hypoxia, and vascularity in bladder tumors: Association with clinical outcomes," Oncology Research, vol. 17, no. 3, pp. 93-101, 2008.
38. M. S. Gee, W. N. Procopio, S. Makonnen, M. D. Feldman, N. M. Yeilding, andW. M. F. Lee, "Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy," The American Journal of Pathology, vol. 162, no. 1, pp. 183-193, 2003.
39. B. Sennino, B. L. Falcón, D. McCauley et al., "Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102," Cancer Research, vol. 67, no. 15, pp. 7358-7367, 2007.
40. V. G. Cooke, V. S. LeBleu, D. Keskin et al., "Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition andmetastasismediated bymet signaling pathway," Cancer Cell, vol. 21, no. 1, pp. 66-81, 2012.
41. A. Abramsson, P. Lindblom, and C. Betsholtz, "Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors," Journal of Clinical Investigation, vol. 112, no. 8, pp. 1142-1151, 2003.
42. M. Hellström, M. Kalén, P. Lindahl, A. Abramsson, and C. Betsholtz, "Role of PDGF-B and PDGFR-α in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in themouse," Development, vol. 126, no. 14, pp. 3047-3055, 1999.
43. N. Reinmuth, W. Liu, Y. D. Jung et al., "Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival.," The FASEB Journal, vol. 15, no. 7, pp. 1239-1241, 2001.
44. C. Sundberg, M. Kowanetz, L. F. Brown, M. Detmar, and H. F. Dvorak, "Stable expression of angiopoietin-1 and other markers by cultured pericytes: Phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo," Laboratory Investigation, vol. 82, no. 4, pp. 387-401, 2002.
45. P. Lindahl, B. R. Johansson, P. Levéen, and C. Betsholtz, "Pericyte loss and microaneurysm formation in PDGF-B-deficient mice," Science, vol. 277, no. 5323, pp. 242-245, 1997.
46. M. Furuhashi, T. Sjöblom, A. Abramsson et al., "Plateletderived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate," Cancer Research, vol. 64, no. 8, pp. 2725-2733, 2004.
47. P. Guo, B. Hu, W. Gu et al., "Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment," The American Journal of Pathology, vol. 162, no. 4, pp. 1083-1093, 2003.
48. K. Y. Aguilera and R. A. Brekken, "Recruitment and retention: Factors that affect pericyte migration," Cellular and Molecular Life Sciences, vol. 71, no. 2, pp. 299-309, 2014.
49. M. R. Mancuso, R. Davis, S. M. Norberg et al., "Rapid vascular regrowth in tumors after reversal of VEGF inhibition," The Journal of Clinical Investigation, vol. 116, no. 10, pp. 2610-2621, 2006.
50. G. Bergers, S. Song, N. Meyer-Morse, E. Bergsland, and D. Hanahan, "Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors," Journal of Clinical Investigation, vol. 111, no. 9, pp. 1287-1295, 2003.
51. R. Erber, A.Thurnher, A.D. Katsen et al., "Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms," The FASEB Journal, vol. 18, no. 2, pp. 338-340, 2004.
52. M.Miljkovic-Licina, P. Hammel, S. Garrido-Urbani et al., "Targeting olfactomedin-like 3 inhibits tumor growth by impairing angiogenesis and pericyte coverage," Molecular Cancer Therapeutics, vol. 11, no. 12, pp. 2588-2599, 2012.
53. E. M. Caspani, P. H. Crossley, C. Redondo-Garcia, S. Martinez, and M. G. Castro, "Glioblastoma: A pathogenic crosstalk between tumor cells and pericytes," PLoS ONE, vol. 9, no. 7, Article ID e101402, 2014.
54. X. Xian, J.Håkansson, A. Ståhlberg et al., "Pericytes limit tumor cell metastasis,"The Journal of Clinical Investigation, vol. 116, no. 3, pp. 642-651, 2006.
55. S. Taniguchi, M. Takeoka, T. Ehara et al., "Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells," Cancer Research, vol. 61, no. 20, pp. 7627-7634, 2001.
56. K. Welén, K. Jennbacken, T. Tesan, and J.-E. Damber, "Pericyte coverage decreases invasion of tumour cells into blood vessels in prostate cancer xenografts," Prostate Cancer and Prostatic Diseases, vol. 12, no. 1, pp. 41-46, 2009.
57. V. Agrawal, S. Maharjan, K. Kim et al., "Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice," Oncotarget, vol. 5, no. 9, pp. 2761-2777, 2014.
58. Y. Kienast, L. von Baumgarten, M. Fuhrmann et al., "Real-time imaging reveals the single steps of brain metastasis formation," Nature Medicine, vol. 16, no. 1, pp. 116-122, 2010.
59. J. C. Welti, T. Powles, S. Foo et al., "Contrasting effects of sunitinibwithin in vivo models of metastasis," Angiogenesis, vol. 15, no. 4, pp. 623-641, 2012.
60. C.M.Ghajar,H. Peinado,H.Mori et al., "Theperivascularniche regulates breast tumour dormancy," Nature Cell Biology, vol. 15, no. 7, pp. 807-817, 2013.
61. B. Meyrick and L. Reid, "The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study," Laboratory Investigation, vol. 38, no. 2, pp. 188-200, 1978.
62. K. Sato and M. R. Urist, "Induced regeneration of calvaria by bone morphogenetic protein (BMP) in dogs," Clinical Orthopaedics and Related Research, vol. 197, pp. 301-311, 1985.
63. C. Farrington-Rock, N. J. Crofts, M. J. Doherty, B. A. Ashton, C. Griffin-Jones, and A. E. Canfield, "Chondrogenic and adipogenic potential of microvascular pericytes," Circulation, vol. 110, no. 15, pp. 2226-2232, 2004.
64. A. Dellavalle, M. Sampaolesi, R. Tonlorenzi et al., "Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells," Nature Cell Biology, vol. 9, no. 3,pp. 255-267, 2007.
65. P. Dore-Duffy, A. Katychev, X. Wang, and E. van Buren, "CNS microvascular pericytes exhibit multipotential stem cell activity," Journal of Cerebral Blood FlowandMetabolism, vol. 26, no. 5, pp. 613-624, 2006.
66. F.-J. Lv, R. S. Tuan, K. M. C. Cheung, and V. Y. L. Leung, "Concise review: The surface markers and identity of human mesenchymal stem cells," Stem Cells, vol. 32, no. 6, pp. 1408-1419, 2014.
67. A. Caplan, "All MSCs are pericytes?" Cell Stem Cell, vol. 3, no. 3, pp. 229-230, 2008.
68. A. Blocki, Y. Wang, M. Koch et al., "Not all MSCs can act as pericytes: Functional in vitro assays to distinguish pericytes fromothermesenchymal stem cells in angiogenesis," Stem Cells and Development, vol. 22, no. 17, pp. 2347-2355, 2013.
69. R. Muramatsu and T. Yamashita, "Pericyte function in the physiological central nervous system," Neuroscience Research, vol. 81-82, pp. 38-41, 2014.
70. G. Paul, I. Özen, N. S. Christophersen et al., "The adult human brain harbors multipotent perivascular mesenchymal stem cells," PLoS ONE, vol. 7, no. 4,Article ID e35577, 2012.
71. C. Calabrese, H. Poppleton, M. Kocak et al., "A perivascular niche for brain tumor stem cells," Cancer Cell, vol. 11, no. 1, pp. 69-82, 2007.
72. L. Cheng, Z. Huang, W. Zhou et al., "Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth," Cell, vol. 153, no. 1, pp. 139-152, 2013.
73. R. Wang, K. Chadalavada, J. Wilshire et al., "Glioblastoma stemlike cells give rise to tumour endothelium," Nature, vol. 468, no. 7325, pp. 829-833, 2010.
74. F. Appaix, M. F. Nissou, B. van der Sanden et al., "Brain mesenchymal stem cells: The other stem cells of the brain?" World Journal of Stem Cells, vol. 6, no. 2, pp. 134-143, 2014.
75. V. S.Rajkumar, K. Howell,K.Csiszar,C.P.Denton, C. M. Black, and D. J. Abraham, "Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis," Arthritis Research &Therapy, vol. 7, no. 5, pp. 1113-1123, 2005.
76. S.-L. Lin, T. Kisseleva, D. A. Brenner, and J. S. Duffield, "Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney," The American Journal of Pathology, vol. 173, no. 6, pp. 1617-1627, 2008.
77. I. Ozen, T. Deierborg, K. Miharada et al., "Brain pericytes acquire a microglial phenotype after stroke," Acta Neuropathologica, vol. 128, no. 3, pp. 381-396, 2014.
78. T. Nakagomi, S. Kubo, A. Nakano-Doi et al., "Brain vascular pericytes following ischemia have multipotential stem cell activity to differentiate into neural and vascular lineage cells," Stem Cells, 2015.
79. G. C.Daginakatte, S. M.Gianino,N. W. Zhao,A. S. Parsadanian, and D. H. Gutmann, "Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation," Cancer Research, vol. 68, no. 24, pp. 10358-10366, 2008.
80. A. Ellert-Miklaszewska, M. Dabrowski, M. Lipko, M. Sliwa, M. Maleszewska, and B. Kaminska, "Molecular definition of the pro-tumorigenic phenotype of glioma-activated microglia," Glia, vol. 61, no. 7, pp. 1178-1190, 2013.
81. L. E. Olson and P. Soriano, "PDGFR signaling regulates mural cell plasticity and inhibits fat development," Developmental Cell, vol. 20, no. 6, pp. 815-826, 2011.
82. E. A. Winkler, R. D. Bell, and B. V. Zlokovic, "Central nervous system pericytes in health and disease," Nature Neuroscience, vol. 14, no. 11, pp. 1398-1405, 2011.
83. H. K. Rucker, H. J. Wynder, and W. E. Thomas, "Cellular mechanisms of CNS pericytes," Brain Research Bulletin, vol. 51, no. 5, pp. 363-369, 2000.
84. C. Pieper, J. J. Marek, M. Unterberg, T. Schwerdtle, and H.- J. Galla, "Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro," Brain Research, vol. 1550, pp. 1-8, 2014.
85. C. Pieper, P. Pieloch, and H.-J. Galla, "Pericytes support neutrophil transmigration via interleukin-8 across a porcine coculture model of the blood-brain barrier," Brain Research, vol. 1524, pp. 1-11, 2013.
86. J. Hamzah, M. Jugold, F. Kiessling et al., "Vascular normalization in Rgs5-deficient tumours promotes immune destruction," Nature, vol. 453, no. 7193, pp. 410-414, 2008.
87. A. Bose, S. Barik, S. Banerjee et al., "Tumor-derived vascular pericytes anergizeThcells," Journal of Immunology, vol. 191, no. 2, pp. 971-981, 2013.
88. B. Merelli, D. Massi, L. Cattaneo, and M. Mandalà, "Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities," Critical Reviews in Oncology/ Hematology, vol. 89, no. 1, pp. 140-165, 2014.
89. K. Ochs, F. Sahm, C. A. Opitz et al., "Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma," Journal of Neuroimmunology, vol. 265, no. 1-2, pp. 106-116, 2013.